Abstract 1887P
Background
Palliative care patients experience chronic sorrow due to living loss such as impairment in bodily functions, inability to carry out daily life, and meaninglessness due to impending death. Logotherapy was shown to be an effective method to cope with end-of-life related distress. The aim of this study was to investigate effectiveness of logotherapy on chronic sorrow, dignity, and meaning in life on palliative care patients.
Methods
This randomized-controlled study was conducted between September 2021-June 2023 in medical and gynecological oncology clinics of a university hospital, with 58 adult advanced cancer patients requiring palliative care. Participants were assigned to either intervention (n=29) or control (n=29) group by simple randomization via a computer program. Participants, ≥18 years old, having advanced solid cancer, aware of their diagnosis, having no communication problem or mental disorder, with a life expectancy over 6 months and Palliative Performance Scale score ≥%50, and verbally expressing to experience chronic sorrow were included. Data were collected with demographic form, Patient Dignity Inventory (PDI), Prolonged Grief Disorder Scale-Patient Form (PGD-PF), presence of meaning (MIL-PM) and search for meaning (MIL-SM) subdimensions of Meaning in Life (MIL) Questionnaire. Data were collected on admission, at the 4th and 8th weeks. Intervention group received logotherapy, lasting about of 45 minutes, 2 days a week for 4 weeks. Control group received routine care.
Results
The mean scores of PDI (p=0.01), PGD-PF (p=0.01) and MIL-SM (p=0.11) were lower in the intervention group, while MIL-PM was higher (p=0.02). Within group analysis showed a decrease in PDI (p<0.01), PGD-PF (p=0.01), MIL-SM (p=0.02), and increase in MIL-PM (p<0.01) in the intervention group while mean scores of PDI (p=0.01), PGD-PF (p=0.01), MIL-SM (p=0.04), and MIL-PM (p=0.05) decreased in control group.
Conclusions
Logotherapy was found effective on decreasing sorrow and dignity related distress of palliative care patients, while increasing finding meaning in life.
Clinical trial identification
NCT05129059.
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1873P - Thalidomide for the treatment of chemotherapy-induced night sweats in patients with pancreatic cancer
Presenter: Nan Lu
Session: Poster session 12
1874P - Time to vomiting after chemotherapy in association with number of emetic risk factors among breast cancer patients receiving highly emetogenic chemotherapy
Presenter: Winnie Yeo
Session: Poster session 12
1875P - Real-world evidence of ribociclib induced liver toxicity in patients with breast cancer: A multi-center experience
Presenter: Onur Bas
Session: Poster session 12
1877P - Adverse effects (AEs) of trastuzumab deruxtecan (T-DXd) in solid tumours: A meta-analysis
Presenter: Neha Pathak
Session: Poster session 12
1878P - Efficacy of surgical gloves (SG) as compression therapy to prevent oxaliplatin-induced peripheral neuropathy (PN): The ELEGANT trial
Presenter: Aurélia JOUREAU-CHABERT
Session: Poster session 12
1879P - Effectiveness of intravenous fosnetupitant & palonosetron for cinv prophylaxis in patients receiving highly emetogenic chemotherapy regimens: Subgroup analysis from a phase IV Indian study
Presenter: Arun Kumar Verma
Session: Poster session 12
1880P - Antiemetic prophylaxis during chemoradiation: Sub-study of the GAND-emesis trial identifying dosimetric predictors for vomiting
Presenter: Anika Johannsdottir
Session: Poster session 12
1881P - Enhancing chemotherapy-induced nausea and vomiting management: Insights into guideline adherence and patient outcomes
Presenter: Suresh Attili
Session: Poster session 12
1882P - Awareness of chemotherapy induced nausea and vomiting and adherence to guidelines: A multinational and multicenter survey
Presenter: Ricardo Caponero
Session: Poster session 12
1883P - Impact of geriatrician-implemented Interventions on chemotherapy (CT) delivery in vulnerable elderly patients with early or advanced solid tumors: The GIVE trial
Presenter: Emanuela Risi
Session: Poster session 12